- Home
- Personal stories
Personal stories
-
What to know about HDFN, a serious blood disorder in babies, including a possible new treatment
Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder. -
The quest to help patients with a deadly type of lung cancer
Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. For Lung Cancer Awareness Month, they share their journey. -
Prioritizing health worker mental health and well-being is critical to achieving healthcare goals
Health worker burnout was reaching a crisis point even before COVID-19. Tackling burnout needs to begin with addressing the stigma among health workers to reach out for mental health support. -
5 impactful ways Johnson & Johnson supports nurses and the incredible work they do
From mental health and resilience programs to Hackathons to essential podcasts, here are a few recent ways the company is championing frontline workers. -
Meet Teresa Harrison, who is changing how mental healthcare is being delivered in Grimsby, UK
A new model in community-based mental health support pioneered by Mental Health UK is improving quality of life for patients and helping to ease over-burdened primary care practices. -
Johnson & Johnson named to the TIME100 Most Influential Companies list
The company is honored to be recognized for its leadership in helping shape the trajectory of healthcare around the world. -
Conduit interview with Kris Sterkens
“We’re supporting the power of local ideas to create real, sustainable change.” -
What you need to know about Johnson & Johnson’s 2021 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses. -
2 pandemics, 1 goal: Meet 4 innovators with high-tech ideas for fighting tuberculosis in the time of COVID-19
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who’ve made it their mission to move the world closer to the goal of ending tuberculosis. -
Kenya launches new community health strategy
Co-created by the Johnson & Johnson Center for Health Worker Innovation with the Ministry of Health and other stakeholders, the effort aims to integrate community health workers formally into the health system.